ST. PAUL, Minn.--(BUSINESS WIRE)--Minnetronix announced today the exclusive licensing rights of Penn State Research Foundation’s wireless energy transmission technology for assist devices in the treatment of Congestive Heart Failure. Wireless energy transmission technology enables therapies for Congestive Heart Failure, such as Left Ventricular Assist Devices (LVAD), to become fully implantable and Penn State is one of only two organizations in the world to have developed and deployed such a system clinically.
